tiprankstipranks
Advertisement

SCHY - ETF AI Analysis

Compare

Top Page

SCHY

Schwab International Dividend Equity ETF (SCHY)

Rating:62Neutral
Price Target:
SCHY’s rating suggests it is a solid but not top-tier international dividend ETF, supported by strong holdings like TotalEnergies, GlaxoSmithKline, and Roche, which bring solid financial performance, attractive valuations, and strategic growth initiatives. However, some key positions such as Wesfarmers and Enel face issues like bearish technical trends, high leverage, or potential overvaluation, and the fund’s focus on a relatively small group of large international dividend payers means investors should be aware of concentration risk in specific sectors and regions.
Positive Factors
Strong Year-To-Date Performance
The ETF has delivered strong gains so far this year, showing solid recent momentum for investors.
Leading Holdings With Solid Results
Several of the largest positions, including DHL Group, ENI, TotalEnergies, Wesfarmers, and Enel, have shown strong performance, helping support the fund’s returns.
Low Expense Ratio
The fund charges a very low fee, which helps investors keep more of the returns generated by the portfolio.
Negative Factors
Mixed Performance Among Top Holdings
Some major holdings like Unilever and Vinci have shown weaker or slightly negative performance, which can drag on overall results.
High Country Concentration
A large share of the portfolio is concentrated in a few countries such as the UK, Australia, France, Italy, and Germany, increasing sensitivity to economic or political issues in those markets.
Sector Tilt Toward General and Defensive Names
The heavy weight in the broad “General” category and consumer defensive stocks may limit upside if more growth-oriented sectors outperform.

SCHY vs. SPDR S&P 500 ETF (SPY)

SCHY Summary

SCHY is the Schwab International Dividend Equity ETF, which follows the Dow Jones International Dividend 100 Index. It invests in large and mid-sized companies outside the U.S. that pay relatively high dividends. The fund holds well-known names like Unilever and Roche, along with many other firms across Europe, Asia, and beyond. Investors might consider SCHY if they want steady income from dividends plus diversification away from only U.S. stocks. A key risk is that international stock prices and currencies can go up and down, so the value of the ETF and its income are not guaranteed.
How much will it cost me?The Schwab International Dividend Equity ETF (SCHY) has an expense ratio of 0.08%, which means you’ll pay $0.80 per year for every $1,000 invested. This is lower than average because SCHY is passively managed, tracking an index rather than relying on active stock picking.
What would affect this ETF?SCHY's focus on high dividend yields from international markets could benefit from stable economic growth in developed countries outside the U.S., as well as increased demand for defensive sectors like Consumer Defensive and Health Care during uncertain times. However, the ETF may face challenges from rising interest rates, which can make dividend-paying stocks less attractive, and potential regulatory changes or economic slowdowns in key regions where its top holdings operate. Geographic diversification helps mitigate some risks, but currency fluctuations and geopolitical tensions could also impact performance.

SCHY Top 10 Holdings

SCHY leans heavily on a mix of European consumer staples and energy names, giving the fund a steady, income-focused feel. DHL Group and energy giants TotalEnergies and ENI have been doing the heavy lifting lately, with their shares rising and helping drive recent performance. Healthcare leaders like Roche are also pulling their weight, while Unilever and GlaxoSmithKline look more mixed, occasionally losing steam. Vinci has been lagging, acting as a small drag. Overall, it’s a globally diversified, ex-U.S. dividend play with a clear tilt toward Europe’s defensive and energy sectors.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Unilever4.41%$110.73M£102.18B-5.69%
72
Outperform
Wesfarmers Limited4.25%$106.74MAU$101.45B10.54%
68
Neutral
Roche Holding AG4.24%$106.43M$348.49B38.24%
73
Outperform
DHL Group4.16%$104.63M€64.65B47.44%
76
Outperform
GlaxoSmithKline3.99%$100.32M£77.40B36.54%
77
Outperform
British American Tobacco3.97%$99.84M£98.57B6.74%
71
Outperform
Enel S.p.A.3.92%$98.37M€99.52B26.11%
67
Neutral
ENI S.p.A.3.87%$97.26M€70.14B61.67%
63
Neutral
Vinci SA3.77%$94.74M€68.99B4.89%
76
Outperform
TotalEnergies SE3.73%$93.73M€170.58B50.93%
78
Outperform

SCHY Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
32.19
Positive
100DMA
31.94
Positive
200DMA
30.86
Positive
Market Momentum
MACD
0.38
Negative
RSI
65.61
Neutral
STOCH
90.51
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SCHY, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 32.68, equal to the 50-day MA of 32.19, and equal to the 200-day MA of 30.86, indicating a bullish trend. The MACD of 0.38 indicates Negative momentum. The RSI at 65.61 is Neutral, neither overbought nor oversold. The STOCH value of 90.51 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SCHY.

SCHY Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$2.54B0.08%
62
Neutral
$8.73B0.07%
68
Neutral
$8.45B0.50%
59
Neutral
$533.13M0.45%
58
Neutral
$196.89M0.75%
62
Neutral
$16.31M0.39%
65
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SCHY
Schwab International Dividend Equity ETF
33.35
6.89
26.04%
SPYD
SPDR Portfolio S&P 500 High Dividend ETF
IDV
iShares International Select Dividend ETF
DWX
SPDR S&P International Dividend ETF
IDVZ
Opal International Dividend Income ETF
VDI
Virtus International Dividend ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement